Lycorine, a candidate for the control of period length in mammalian cells

Cellular Physiology and Biochemistry

Volumn 29, Issue 3-4, 2012, Pages 407-416

  Onishi, Yoshiaki ^a   Kawano, Yasuhiro ^a   Yamazaki, Yoshimitsu ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Alkaloid; Circadian rhytm; Transcription

Indexed keywords

AMARYLLIDACEAE ALKALOID; CYCLOHEXIMIDE; LYCORICIDINOL; LYCORINE; PROTEIN BMAL1; UNCLASSIFIED DRUG;

AMARYLLIDACEAE; ANIMAL CELL; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; IN VITRO STUDY; MAMMAL CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

AMARYLLIDACEAE; LYCORIS; MAMMALIA;

AMARYLLIDACEAE ALKALOIDS; ANIMALS; ARNTL TRANSCRIPTION FACTORS; CELL NUCLEUS; CIRCADIAN RHYTHM; CYCLOHEXIMIDE; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; LYCORIS; MAMMALS; MICE; NIH 3T3 CELLS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 1; PHENANTHRIDINES; PHOSPHORYLATION; PLASMIDS; PROTEIN BIOSYNTHESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84859896736     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000338495     Document Type: Article

References (36)

1. Bunger MK, Wilbacher LD, Moran SM, Clendenin C, Radcliffe LA, Hogenesch JB, Simon MC, Takahashi JS, Bradfield CA: Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 2000;103:1009-1017. (Pubitemid 32037390)
2. Ueda HR, Chen W, Adachi A, Wakamatsu H, Hayashi S, Takasugi T, Nagano M, Nakahama K, Suzuki Y, Sugano S, Iino M, Shigeyoshi Y, Hashimoto S: A transcription factor response element for gene expression during circadian night. Nature 2002;418:534-539. (Pubitemid 34851399)
3. Onishi Y, Hanai S, Ohno T, Hara Y, Ishida N: Rhythmic SAF-A binding underlies circadian transcription of the Bmal1 gene. Mol Cell Biol 2008;28:3477-3488. (Pubitemid 351657109)
4. Reppert SM, Weaver DR: Coordination of circadian timing in mammals. Nature 2002;418:935-941. (Pubitemid 34976023)
5. Bechtold DA, Gibbs JE, Loudon AS: Circadian dysfunction in disease. Trends Pharmacol Sci 2010;31:191-198.
6. Weldemichael DA, Grossberg GT: Circadian rhythm disturbances in patients with Alzheimer's disease: a review. Int J Alzheimers Dis 2010;2010:pii:716453.
7. Adams M, Gmunder F, Hamburger M: Plants traditionally used in age related brain disorders-a survey of ethnobotanical literature. J Ethnopharmacol 2007;113:363-381. (Pubitemid 47361572)
8. Jin Z: Amaryllidaceae and Sceletium alkaloids. Nat Prod Rep 2007;24:886-905. (Pubitemid 47108191)
9. Heinrich M, Lee Teoh H: Galanthamine from snowdrop-the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. J Ethnopharmacol 2004;92:147-162. (Pubitemid 38610095)
10. Yamazaki Y, Kawano Y: Inhibitory Effects of Herbal Alkaloids on the TNF- á and Nitric Oxide Production in Lipopolysaccharide-stimulated RAW264 Macrophages. Chem Pharm Bull (Tokyo) 2011;59:388-391.
11. Onishi Y, Oishi K, Kawano Y, Yamazaki Y: The harmala alkaloid, harmine is a modulator of circadian Bmal1 transcription. Biosci Rep 2011;32:45-52.
12. Lamoral-Theys D, Decaestecker C, Mathieu V, Dubois J, Kornienko A, Kiss R, Evidente A, Pottier L: Lycorine and its derivatives for anticancer drug design. Mini Rev Med Chem 2010;10:41-50.
13. Lopez S, Bastida J, Viladomat F, Codina C: Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts. Life Sci 2002;71:2521-2529. (Pubitemid 35247960)
14. Welsh DK, Imaizumi T, Kay SA: Realtime reporting of circadian-regulated gene expression by luciferase imaging in plants and mammalian cells. Methods Enzymol 2005;393:269-288. (Pubitemid 40486528)
15. Ohno T, Onishi Y, Ishida N: The negative transcription factor E4BP4 is associated with circadian clock protein PERIOD2. Biochem Biophys Res Commun 2007;354:1010-1015. (Pubitemid 46216237)
16. Vrijsen R, Vanden Berghe DA, Vlietinck AJ, Boeye A: Lycorine: a eukaryotic termination inhibitor? J Biol Chem 1986;261:505-507. (Pubitemid 16161696)
17. Adolph S, Brusselbach S, Muller R: Inhibition of transcription blocks cell cycle progression of NIH3T3 fibroblasts specifically in G1. J Cell Sci 1993;105:113-122. (Pubitemid 23187551)
18. Liu J, Hu WX, He LF, Ye M, Li Y: Effects of lycorine on HL-60 cells via arresting cell cycle and inducing apoptosis. FEBS Lett 2004;578:245-250. (Pubitemid 39601789)
19. Tamaru T, Isojima Y, van der Horst GT, Takei K, Nagai K, Takamatsu K: Nucleocytoplasmic shuttling and phosphorylation of BMAL1 are regulated by circadian clock in cultured fibroblasts. Genes Cells 2003;8:973-983. (Pubitemid 38072273)
20. Toriizuka Y, Kinoshita E, Kogure N, Kitajima M, Ishiyama A, Otoguro K, Yamada H, Omura S, Takayama H: New lycorine-type alkaloid from Lycoris traubii and evaluation of antitrypanosomal and antimalarial activities of lycorine derivatives. Bioorg Med Chem 2008;16:10182-10189. (Pubitemid 50331576)
21. Ceriotti G: Narciclasine: an antimitotic substance from Narcissus bulbs. Nature 1967;213:595-596.
22. Arrigoni O: Ascorbate system in plant development. J Bioenerg Biomembr 1994;26:407-419. (Pubitemid 24321067)
23. Yui S, Mikami M, Kitahara M, Yamazaki M: The inhibitory effect of lycorine on tumor cell apoptosis induced by polymorphonuclear leukocyte-derived calprotectin. Immunopharmacology 1998;40:151-162. (Pubitemid 28439169)
24. Karadeniz H, Gulmez B, Sahinci F, Erdem A, Kaya GI, Unver N, Kivcak B, Ozsoz M: Disposable electrochemical biosensorfor the detection of the interaction between DNA and lycorine based on guanine and adenine signals. J Pharm Biomed Anal 2003;33:295-302. (Pubitemid 37101446)
25. Zee-Cheng RK, Yan SJ, Cheng CC: Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction. J Med Chem 1978;21:199-203. (Pubitemid 8269367)
26. Kojima S, Shingle DL, Green CB: Posttranscriptional control of circadian rhythms. J Cell Sci 2011;124:311-320.
27. Hastings JW: The Gonyaulax clock at 50: translational control of circadian expression. Cold Spring Harb Symp Quant Biol 2007;72:141-144.
28. Xavier S, Gilbert V, Rastaldi MP, Krick S, Kollins D, Reddy A, Bottinger E, Cohen CD, Schlondorff D: BAMBI is expressed in endothelial cells and is regulated by lysosomal/autolysosomal degradation. PLoS ONE 2010;5:e12995.
29. Nguyen T, Sherratt PJ, Huang HC, Yang CS, Pickett CB: Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J Biol Chem 2003;278:4536-4541. (Pubitemid 36800950)
30. Unsal-Kacmaz K, Mullen TE, Kaufmann WK, Sancar A: Coupling of human circadian and cell cycles by the timeless protein. Mol Cell Biol 2005;25:3109-3116. (Pubitemid 40464313)
31. Lee Y, Chen R, Lee HM, Lee C: Stoichiometric relationship among clock proteins determines robustness of circadian rhythms. J Biol Chem 2011;286:7033-7042.
32. Duplus E, Gras C, Soubeyre V, Vodjdani G, Lemaigre-Dubreuil Y, Brugg B: Phosphorylation and transcriptional activity regulation of retinoid-related orphan receptor alpha 1 by protein kinases C. J Neurochem 2008;104:1321-1332. (Pubitemid 351293337)
33. Lee HM, Chen R, Kim H, Etchegaray JP, Weaver DR, Lee C: The period of the circadian oscillator is primarily determined by the balance between casein kinase 1 and protein phosphatase 1. Proc Natl Acad Sci USA 2011;108:16451-16456.
34. Kang J, Zhang Y, Cao X, Fan J, Li G, Wang Q, Diao Y, Zhao Z, Luo L, Yin Z: Lycorine inhibits lipopolysaccharideinduced iNOS and COX-2 up-regulation in RAW264.7 cells through suppressing P38 and STATs activation and increases the survival rate of mice after LPS challenge. Int Immunopharmacol 2012;12:249-256.
35. Ohdo S: Chronopharmaceutics: pharmaceutics focused on biological rhythm. Biol Pharm Bull 2010;33:159-167.
36. Nieoullon A, Bentue-Ferrer D, Bordet R, Tsolaki M, Forstl H: Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine. Curr Med Res Opin 2008;24:3357-3367.